Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2022 Feb;58(2):T150-T158.
doi: 10.1016/j.arbres.2021.05.032. Epub 2022 Feb 14.

[Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies

[Article in English, Spanish]
Vicente Plaza  1 , Isam Alobid  2 , Cesáreo Alvarez  3 , Marina Blanco  4 , Jorge Ferreira  5 , Gabriel García  6 , Antonio Gómez-Outes  7 , Fernando Gómez  8 , Antonio Hidalgo  9 , Javier Korta  10 , Jesús Molina  11 , Francisco Javier Pellegrini  12 , Montserrat Pérez  13 , Javier Plaza  14 , Manuel Praena  15 , Santiago Quirce  16 , José Sanz  17
Affiliations
Practice Guideline

[Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies

[Article in English, Spanish]
Vicente Plaza et al. Arch Bronconeumol. 2022 Feb.

Abstract

In this fifth phase of development, the contents of the Spanish Asthma Management Guidelines (GEMA), which include versions 5.0 and 5.1, have undergone a thorough review. The aim here is to set the main changes in context. These could be summarized as follows: DIAGNOSIS: new FENO cut-off and severity classification based on treatment needed to maintain control; INTERMITTENT ASTHMA: a more restrictive concept and treatment extended to include a glucocorticoid/adrenergic combination as needed; MILD ASTHMA: glucocorticoid/adrenergic therapy as needed as an alternative in case of low therapeutic adherence to conventional fixed-dose steroids; SEVERE ASTHMA: readjustment of phenotypes, incorporation of triple therapy in a single inhaler, and criteria for selection of a biologic in severe uncontrolled asthma; OTHERS: specific scoring in childhood asthma, incorporation of certain organizational aspects (care circuits, asthma units, telemedicine), new sections on COVID-19 and nasal polyposis.

Keywords: Asma; Asthma; Clinical practice guidelines; Consenso; Consensus; Evidence-based medicine; Guía de práctica clínica; Medicina basada en la evidencia.

PubMed Disclaimer

Publication types